Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based iPSC and bio data ...
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Ideal Power Third Quarter 2024 Results Call. [Operator Instructions] As a reminder, ...
Q4 2024 Earnings Call Transcript November 14, 2024 Operator: Welcome to the Applied Materials Fourth Quarter Fiscal 2024 ...
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T cell therapy ...